Immunohistochemistry of neuroblastoma tumours demonstrates that (i) synaptophysin is constitutively expressed by neuroblastoma tumoural cells, (ii) NEFL gene mutation is common yet inefficient in neuroblastoma tumours, and (iii) neuron-specific enolase (ENO2) is a non-favourable marker. This evidence concerns the gene ENO2 and neuroblastoma.